(Q44880279)

7 December 2017

title

A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis (English)

1 reference

randomized controlled trial

7 December 2017

main subject

1 reference

Sylvie Naveau

1

1 reference

7 December 2017

Sylvie Chollet-Martin

2

1 reference

7 December 2017

Sébastien Dharancy

3

1 reference

7 December 2017

Philippe Mathurin

4

1 reference

7 December 2017

Pauline Jouet

5

1 reference

7 December 2017

Marie-Astrid Piquet

6

1 reference

7 December 2017

Thierry Davion

7

1 reference

7 December 2017

Frédéric Oberti

8

1 reference

7 December 2017

Philippe Broët

9

1 reference

7 December 2017

Dominique Emilie

10

1 reference

7 December 2017

Foie-Alcool group of the Association Française pour l'Etude du Foie

11

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

7 December 2017

1 reference

7 December 2017

volume

39

1 reference

7 December 2017

issue

5

1 reference

7 December 2017

page(s)

1390-1397

1 reference

Cytokines in alcoholic and nonalcoholic steatohepatitis

7 December 2017

cites work

1 reference

Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.

21 January 2018

1 reference

Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology

21 January 2018

1 reference

Infliximab for the treatment of fistulas in patients with Crohn's disease

21 January 2018

1 reference

Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study

21 January 2018

1 reference

Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis.

21 January 2018

1 reference

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

21 January 2018

1 reference

Anti-cytokine therapeutics and infections

21 January 2018

1 reference

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

21 January 2018

1 reference

The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients

21 January 2018

1 reference

Anti-tumor necrosis factor-alpha therapy in severe alcoholic hepatitis: are large randomized trials still possible?

21 January 2018

1 reference

Blood neutrophil functions and cytokine release in severe alcoholic hepatitis: effect of corticosteroids

21 January 2018

1 reference

Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat

21 January 2018

1 reference

7 January 2021

Alcoholic hepatitis--glucocorticosteroids or not?

1 reference

7 January 2021

Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials

1 reference

7 January 2021

Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial

1 reference

7 January 2021

Infliximab: a review of its use in Crohn's disease and rheumatoid arthritis

1 reference

7 January 2021

Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety

1 reference

7 January 2021

Group sequential clinical trials with triangular continuation regions.

1 reference

7 January 2021

A unifying family of group sequential test designs

1 reference

7 January 2021

Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy

1 reference

7 January 2021

Neutralization of TNF by the antibody cA2 reveals differential regulation of adhesion molecule expression on TNF-activated endothelial cells.

1 reference

7 January 2021

Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway

1 reference

7 January 2021

Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophages

1 reference

7 January 2021

TNF-α Induces Phosphorylation of p47phox in Human Neutrophils: Partial Phosphorylation of p47phox Is a Common Event of Priming of Human Neutrophils by TNF-α and Granulocyte-Macrophage Colony-Stimulating Factor

1 reference

7 January 2021

Bacterial infections in patients with cirrhosis

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20206

1 reference

7 December 2017

1 reference